Willem Beyen

Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA.

Waterleau NV engages in the provision of water technology services. It offers solutions for water, wastewater, air, and new energy. Its solutions are designed for managing the complete water cycle from process water and drinking water production, over wastewater treatment and discharge compliance to energy, water and nutrient recovery. The company was founded by Luc Vriens, Eddy Frans, Jean-Marie Ghislain, Willy Gils, Ron Gerards and Bernard Lemaitre in 2000 and is headquartered in Wespelaar, Belgium.

Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.

FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen.

Arthur D. Little Benelux NV SA is a global management consultancy specializing in strategy and operations management, serving major corporations and organizations worldwide. They are recognized as leaders in linking strategy, innovation and technology to solve their clients' most complex business issues, delivering sustainable solutions. They are distinguished from others by their deep industry insight and technology expertise. The company was founded in 1967 and is headquartered in Brussels, Belgium.

Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium.

Erytech Pharma, Inc. operates as a biopharmaceutical company. The private company is based in Cambridge, MA.